Madrigal Pharmaceuticals (MDGL) Net Cash Flow (QoQ) (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Madrigal Pharmaceuticals | 15.77 Bn | 15.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 127.94% |
| Dec 31, 2025 | -188.51% |
| Sep 30, 2025 | 4,199.21% |
| Jun 30, 2025 | -96.95% |
| Mar 31, 2025 | 163.04% |
| Dec 31, 2024 | 49.35% |
| Sep 30, 2024 | -113.08% |
| Jun 30, 2024 | -123.52% |
| Mar 31, 2024 | 1,280.35% |
| Dec 31, 2023 | 350.05% |
| Sep 30, 2023 | 58.07% |
| Jun 30, 2023 | 83.45% |
| Mar 31, 2023 | -180.17% |
| Dec 31, 2022 | 4,385.98% |
| Sep 30, 2022 | -44.79% |
| Jun 30, 2022 | 82.77% |
| Mar 31, 2022 | 146.59% |
| Dec 31, 2021 | -182.54% |
| Sep 30, 2021 | 246.59% |
| Jun 30, 2021 | -8.84% |